Comparative effects of dopamine D1 and D2 receptor antagonists on nerve growth factor protein induction

European Journal of Pharmacology

Volumn 402, Issue 1-2, 2000, Pages 39-44

  Ozaki, Takahiro ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetylcholine; Cognition; Dopamine receptor; Extrapyramidal symptom; Nerve growth factor (NGF)

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NERVE GROWTH FACTOR; SULPIRIDE;

ADOLESCENT; AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; CORPUS STRIATUM; EXTRAPYRAMIDAL SYMPTOM; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN INDUCTION; PYRIFORM CORTEX; WESTERN BLOTTING;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; BRAIN CHEMISTRY; DOPAMINE ANTAGONISTS; GENE EXPRESSION REGULATION; GENES, FOS; GENES, JUN; HALOPERIDOL; IMMUNOHISTOCHEMISTRY; MALE; MICE; NERVE GROWTH FACTOR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SULPIRIDE;

EID: 0034683195     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00493-3     Document Type: Article

References (23)

1. Aronin N., Chase K., Sagar S.M., Sharp F.R., Difiglia M. N-Methyl-D-aspartate receptors activation in the neostriatum increases c-fos and fos-related antigens selectively in medium sized neurons. Neuroscience. 44:1991;409-420.
2. Carlsson A., Hansson L., Waters N., Carlsson M. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. Life Sci. 61:1997;75-94.
3. Clary D.O., Weskamp G., Austin L.R., Reichardt L.F. TrkA cross-linking mimics neuronal responses to nerve growth factor. Mol. Biol. Cell. 5:1994;549-563.
4. D'Mello S.R., Heinrich G. Multiple signaling pathways interact in the regulation of nerve growth factor production in L929 fibroblasts. J. Neurochem. 57:1991;1570-1576.
5. 2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience. 37:1990;287-294.
6. Gage F.G., Chen K.S., Buzsaki G., Armstrong D. Experimental approaches to age-related cognitive impairments. Neurobiol. Aging. 9:1988;645-655.
7. Halazonetis T.D., Georgopoulos K., Greenberg M.E., Leder P. c-Jun dimerizes with itself and with c-Fos forming complexes of different DNA binding affinities. Cell. 55:1988;917-924.
8. Heisenberg C.P., Cooper J.D., Berke J., Sofroniew M.V. NMDA potentiates NGF-induced sprouting of septal cholinergic fibers. NeuroReport. 12:1994;413-416.
9. Hengerer B., Lindholm D., Heumann R., Rüther U., Wagner E.F., Thoenen H. Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc. Natl. Acad. Sci. U. S. A. 87:1990;3899-3903.
10. Knipper M., Berzaghi M.D., Blochl A., Breer H., Thoenen H., Lindholm D. Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain derived neurotrophic factor in the rat hippocampus. Eur. J. Neurosci. 6:1994;668-671.
11. Koliatos V.E., Price D.L., Gouras G.K., Cayouette M.H., Burton L.E., Winslow J.W. Highly selective effects of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons. J. Comp. Neurol. 343:1994;247-262.
12. Lapchak P.A., Jenden D.J., Hefti F. Pharmacological stimulation reveals recombinant human nerve growth factor-induced increases of in vivo hippocampal cholinergic function measured in rats with partial fimbria transections. Neuroscience. 50:1992;847-856.
13. Levi Montalcini R., Aloe L., Alleva E. A role for nerve growth factor in nervous, endocrine and immune systems. Prog. Neuroimmunol. 3:1990;1-10.
14. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:1991;421-451.
15. Morse J.K., Wiegand S.J., Anderson K., You Y.M., Cai N., Carnahan J., Miller J., DiStefano P.S., Altar C.A., Lindsay R.M., Alderson R.F. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J. Neurosci. 13:1993;4146-4156.
16. Ozaki T., Katsumoto E., Yokotani N., Yamagami S. The comparative effects of haloperidol, (-)-sulpiride, and SCH23390 on c-fos and c-jun mRNA expressions, and AP-1 DNA binding activity. Eur. Neuropsychopharmacol. 7:1997;181-187.
17. Ozaki T., Katsumoto E., Mui K., Furutsuka D., Yamagami S. Distribution of Fos- and Jun-related proteins and activator protein-1 composite factors in mouse brain induced by neuroleptics. Neuroscience. 84:1998;1187-1196.
18. 2 receptor antagonists on nerve growth factor mRNA expression. Eur. J. Pharmacol. 369:1999;133-143.
19. Pelleymounter M.A., Cullen M.J., Baker M.B., Gollub M., Wellman C. The effects of intrahippocampal BDNF and NGF on spatial learning in aged Long-Evans rats. Mol. Chem. Neuropathol. 29:1996;211-226.
20. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
21. Sonnenberg J.L., Mitchelmore C., Macgregor-Leon P.F., Hempstead J., Morgan J.I., Curran T. Glutamate receptor agonists increase the expression of Fos, Fra and AP-1 DNA binding activity in the mammalian brain. J. Neurosci. Res. 24:1989;72-80.
22. Van der Zee C.E., Lourenssen S., Stanisz J., Diamond J. NGF deprivation of adult rat brain results in cholinergic hypofunction and selective impairments in spatial learning. Eur. J. Neurosci. 7:1995;160-168.
23. Venero J.L., Knusel B., Beck K.D., Hefti F. Expression of neurotrophin and trk receptor genes in adult rats with fimbria transection: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration. Neuroscience. 59:1994;797-815.